Key facts
- It has raised $500K; the latest was Early Stage VC in Oct 2025.
- Notable investors include Y Combinator, 468 Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Pharmie AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Pharmie AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pharmie AI
Developer of an AI-powered pharmacy management platform intended to streamline pharmacy operations and enhance patient care. The company's platform features an AI assistant that automates administrative tasks, manages workflows, and supports pharmacists, enabling pharmacies to focus more on patient needs and enhance operational efficiency.
- Sector
- Information Technology
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 2
- Website
- pharmie.app/
- Ownership
- Privately Held (backing)
Pharmie AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pharmie AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pharmie AI in its N-PORT filings yet. We sweep new filings monthly.